MDLZ monthly performance report
Explore MDLZ's monthly returns, drawdown, and seasonality trends — updated every month.
MDLZ monthly report
—
Key takeaways
- Mondelez International (MDLZ) closed November 2026 at $67.54, up 4.00% for the month and +18.55% over the trailing 12 months.
- Year-to-date, MDLZ is +25.47%, outperforming the S&P 500 which has returned +10.62% YTD.
- The stock is trading +11.14% versus its 200-day moving average ($60.77), a bullish technical signal.
- Over the past three years, MDLZ has underperformed the S&P 500 by −73.91%, with a relative strength index reading of 56.9.
- Win rate over the trailing 39 months stands at 46.2% — 18 positive months versus 21 negative months.
Mondelez International ended November 2026 at $67.54, posting a monthly return of +4.00%. The S&P 500 returned −0.18% over the same window, leaving relative performance at +4.18%.
The current quarter stands at +16.81% (Q4 2026 (QTD)), while medium-term trend remains constructive: price is +11.14% versus the 200-day moving average ($60.77).
Year-to-date, MDLZ is +25.47% against SPY +10.62%, a gap of +14.84%. The stock is currently −1.76% below its 52-week high, with maximum 3-year drawdown at −32.99%.
| Period | MDLZ | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | +1.47% | −0.36% | +1.84% |
| 1 Week | +2.30% | +2.59% | −0.29% |
| 1 Month | +4.00% | −0.18% | +4.18% |
| 3 Months | +6.18% | −2.37% | +8.55% |
| 6 Months | +9.47% | +0.83% | +8.64% |
| YTD | +25.47% | +10.62% | +14.84% |
| 12 Months | +18.55% | +12.25% | +6.30% |
| 3 Years | −2.54% | +71.37% | −73.91% |
| Rank | Month | Return |
|---|---|---|
| #1 | Oct 2026 | +12.31% |
| #2 | Feb 2025 | +10.76% |
| #3 | Jan 2026 | +8.62% |
| #4 | Jul 2026 | +7.73% |
| #5 | Nov 2023 | +7.33% |
| Rank | Month | Return |
|---|---|---|
| #1 | Dec 2024 | −8.04% |
| #2 | Oct 2025 | −8.02% |
| #3 | Oct 2024 | −7.04% |
| #4 | Sep 2026 | −6.85% |
| #5 | Dec 2025 | −6.50% |
| Quarter | Return |
|---|---|
| Q3 2025 | −7.37% |
| Q4 2025 | −13.83% |
| Q1 2026 | +7.08% |
| Q2 2026 | +0.35% |
| Q3 2026 | −0.03% |
| Q4 2026 (QTD) | +16.81% |
| Year | Return |
|---|---|
| 2023 | +8.67% |
| 2024 | −17.53% |
| 2025 | −9.88% |
| 2026 | +25.47% |
| Metric | Value |
|---|---|
| 52-Week High | $68.75 (2026-11-05) |
| 52-Week Low | $51.20 (2026-01-08) |
| Current Price | $67.54 |
| 200-Day Moving Average | $60.77 |
| Price vs 200DMA | +11.14% |
| 3-Year Maximum Drawdown | −32.99% (2026-01-07) |
| Current Drawdown from 52W High | −1.76% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 56.9 |
| 3-Year Excess Return vs S&P 500 | −73.91% |
| RS Peak | 100 (Nov 2023) |
| RS Trough | 47.4 (Jan 2026) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was MDLZ's return for this report period?
MDLZ returned +4.00% in the latest monthly window ending 2026-11-13.
Has MDLZ outperformed SPY year to date?
YTD MDLZ: +25.47% vs SPY: +10.62%.
What is MDLZ's 12-month return?
+18.55% over the trailing 12 months.
Is MDLZ above or below its 200-day moving average?
Price is +11.14% versus 200DMA ($60.77).
What is the maximum drawdown in the 3-year window?
−32.99% on 2026-01-07.